Inventor
Michael Laird Hurrey
Inventor
San Ramon, CA, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes14%
C07CAcyclic or carbocyclic compounds14%
PatentTitleYear
11,020,384Antiarrhythmic formulation202111,007,185Antiarrhythmic formulation202110,266,539Polymorph of Syk inhibitors20199,657,023'Polymorph of Syk inhibitors'20178,153,668'Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate'20127,605,270'Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2012Patents assigned to VERTEX PHARMA (2)· patent assignee history
2009–2012Based in Maynard, MA, US· patent location history
2012Patents assigned to BLYTHE TODD (1)· patent assignee history
2012Patents assigned to EBERLIN ALEX (1)· patent assignee history
2017–2019Patents assigned to GILEAD CONNECTICUT INC (2)· patent assignee history
2017–2021Based in San Ramon, CA, US· patent location history
2021Patents assigned to INCARDA THERAPEUTICS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD CONNECTICUT INC | 2 | 2017–2019 |
| INCARDA THERAPEUTICS INC | 2 | 2021 |
| VERTEX PHARMA | 2 | 2009–2012 |
| BLYTHE TODD | 1 | 2012 |
| EBERLIN ALEX | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Ramon, California, US | 4 | 2017–2021 |
| Maynard, Massachusetts, US | 2 | 2009–2012 |